ZINC CHLORIDE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Zinc Chloride In Plastic Container patents expire, and what generic alternatives are available?
Zinc Chloride In Plastic Container is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in ZINC CHLORIDE IN PLASTIC CONTAINER is zinc chloride. There are thirty-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the zinc chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc Chloride In Plastic Container
A generic version of ZINC CHLORIDE IN PLASTIC CONTAINER was approved as zinc chloride by EXELA PHARMA on May 21st, 2021.
Summary for ZINC CHLORIDE IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 160 |
Clinical Trials: | 776 |
Patent Applications: | 220 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ZINC CHLORIDE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ZINC CHLORIDE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Nova Scotia Health Authority | Phase 3 |
Abraham Nunes | Phase 3 |
The University of Texas Medical Branch, Galveston | Early Phase 1 |
Pharmacology for ZINC CHLORIDE IN PLASTIC CONTAINER
Drug Class | Copper Absorption Inhibitor |
Physiological Effect | Decreased Copper Ion Absorption |
Anatomical Therapeutic Chemical (ATC) Classes for ZINC CHLORIDE IN PLASTIC CONTAINER
US Patents and Regulatory Information for ZINC CHLORIDE IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | ZINC CHLORIDE IN PLASTIC CONTAINER | zinc chloride | INJECTABLE;INJECTION | 018959-001 | Jun 26, 1986 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |